Humasis ranked among the top searched stocks for 2 days in the past month.


As of 9:30 AM on the 21st, Humasis is trading at 12,600 KRW, up 0.8% from the previous day. This marks a 43.34% increase compared to December 9. Humasis is known as an in vitro diagnostic device company.

Over the past 5 days, individual investors have net purchased 60,094 shares, while foreigners and institutions have net purchased 145,834 shares and 16,826 shares, respectively.


On December 18, Humasis became a market issue with the headline "COVID-19 diagnostic kit enters the US market through Celltrion, causing a surge."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing